CoChat

CRISPR/Cas9‐Multiplexed Editing of Chinese Hamster Ovary B4Gal‐T1, 2, 3, and 4 Tailors N‐Glycan Profiles of Therapeutics and Secreted Host Cell Proteins

Open access
Amann, Thomas, Hansen, Anders Holmgaard, Kol, Stefan, Lee, Gyun Min, Andersen, Mikael Rørdam, Kildegaard, Helene Faustrup · 2018 · Biotechnology Journal
Cited by 37

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

In production of recombinant proteins for biopharmaceuticals, N‐glycosylation is often important for protein efficacy and patient safety. IgG with agalactosylated (G0)‐N‐glycans can improve the activation of the lectin‐binding complement system and be advantageous in the therapy of lupus and virus diseases. In this study, the authors aimed to engineer CHO‐S cells for the production of proteins with G0‐N‐glycans by targeting B4Gal‐T isoform genes with CRISPR/Cas9. Indel mutations in genes encoding B4Gal‐T1, ‐T2, and ‐T3 with and without a disrupted B4Gal‐T4 sequence resulted in only ≈1% galactosylated N‐glycans on total secreted proteins of 3‐4 clones per genotype. The authors revealed that B4Gal‐T4 is not active in N‐glycan galactosylation in CHO‐S cells. In the triple‐KO clones, transiently expressed erythropoietin (EPO) and rituximab harbored only ≈6% and ≈3% galactosylated N‐glycans, respectively. However, simultaneous disruption of B4Gal‐T1 and ‐T3 may decrease cell growth. Altogether, the authors present the advantage of analyzing total secreted protein N‐glycans after disrupting galactosyltransferases, followed by expressing recombinant proteins in selected clones with desired N‐glycan profiles at a later stage. Furthermore, the authors provide a cell platform that prevalently glycosylates proteins with G0‐N‐glycans to further study the impact of agalactosylation on different in vitro and in vivo functions of recombinant proteins.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/biot.201800111

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 37

Metadata

Authors
Amann, T., Hansen, A. H., Kol, S., Lee, G. M., Andersen, M. R., & Kildegaard, H. F.
Venue
Biotechnology Journal
Publisher
Wiley
Published
2018-07-02
Volume
13
Issue
10
Pages
e1800111-e1800111
ISSN
  • 1860-6768 (ISSN-L)
  • 1860-7314
OpenAlex
W2806198647
Cited by
37
References
12
FWCI
1.41
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CRISPR/Cas9‐Multiplexed Editing of Chinese Hamster Ovary B4Gal‐T1, 2, 3, and 4 Tailors N‐Glycan Profiles of Therapeutics and Secreted Host Cell Proteins. https://app.cochat.ai/papers/10.1002/biot.201800111
The paper
Amann, T., Hansen, A. H., Kol, S., Lee, G. M., Andersen, M. R., & Kildegaard, H. F. (2018). CRISPR/Cas9‐Multiplexed Editing of Chinese Hamster Ovary B4Gal‐T1, 2, 3, and 4 Tailors N‐Glycan Profiles of Therapeutics and Secreted Host Cell Proteins. Biotechnology Journal. https://doi.org/10.1002/biot.201800111

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.